Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | PRMT5 | O14744 | 3/20 | 0.41 |
| ▸ | WDR77 | Q9BQA1 | 3/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TRPC3 | Q13507 | 1/20 | 0.41 |
| ▸ | TRPC6 | Q9Y210 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8026883 | 0.83 | HSD11B1 (0.48) | KDM4EALDH1A1HPGDRIPK1HSD11B1 | |
| SCHEMBL3841906 | 0.79 | RIPK1 (0.51) | RIPK1HSD11B1 | |
| SCHEMBL8303313 | 0.79 | TMEM97 (0.58) | BRD4MAOAMAOBRIPK1HSD11B1 | |
| SCHEMBL26984487 | 0.79 | TMEM97 (0.58) | BRD4MAOAMAOBRIPK1HSD11B1 | |
| SCHEMBL27984087 | 0.76 | KDM4E (0.50) | KDM4EALDH1A1HPGDSMN1; SMN2BRD4 | |
| SCHEMBL8781820 | 0.75 | CHRNB2 (0.49) | RIPK1HSD11B1 | |
| SCHEMBL28783781 | 0.75 | ATM (0.42) | KDM4EALDH1A1THRBSMN1; SMN2MEN1 | |
| SCHEMBL6976464 | 0.74 | RIPK1 (0.49) | RIPK1HSD11B1 | |
| SCHEMBL8111442 | 0.73 | CHRNB2 (0.53) | RIPK1HSD11B1PRMT5WDR77 | |
| SCHEMBL8781621 | 0.72 | CHRNB2 (0.46) | RIPK1HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1165218-B1 | DEVICE FOR MIXING AND REACTING MULTIPHASE GASEOUS AND LIQUID MIXTURES AND USE OF THIS DEVICE | BAYER AG (DE) | 2003-05-21 | — | — | EP | claimed |
| EP-4090695-A1 | METHOD FOR THE PRODUCING A POLYCARBONATE WITH IMPROVED RECOVERY OF NON-REACTED DIARYLCARBONATE | Covestro Deutschland AG (DE) | 2022-11-23 | — | — | EP | disclosed |
| WO-2021144212-A1 | METHOD FOR THE PRODUCING A POLYCARBONATE WITH IMPROVED RECOVERY OF NON-REACTED DIARYLCARBONATE | COVESTRO DEUTSCHLAND AG (DE) | 2021-07-22 | — | — | WO | disclosed |
| US-6726354-B1 | Device for mixing and reacting multiphase gaseous and liquid mixtures and use of this device | BAYER AKTIENGESELLSCHAFT (DE) | 2004-04-27 | — | — | US | disclosed |
| US-6548691-B2 | Reacting phosgene and monophenols in an inert solvent, in the presence of alkaline solution and nitrogen base catalyst maintaining a temperature below 50 degrees C | BAYER AKTIENGESELLSCAFT (DE) | 2003-04-15 | — | — | US | disclosed |
| US-20020077446-A1 | Process for producing carbonic acid diaryl ester | BAYER AKTIENGESELLSCHAFT (DE) | 2002-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020077446-A1 | Process for producing carbonic acid diaryl ester | PHGDH, PGLS, PYGL | GAA 784/4885KDM4E 2713/4885ALDH1A1 2954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.